אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cytarabine -

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cytarabine 100 mg/ml - solution for injection - 100 mg/ml - active: cytarabine 100 mg/ml excipient: macrogol 400 trometamol water for injection - cytarabine is indicated primarily for induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.

מלטה - אנגלית - Malta Medicines Authority

strides arcolab international limited - cytarabine 100 mg/ml - solution for infusion or injection

קנדה - אנגלית - Health Canada

agila jamp canada inc - cytarabine - solution - 100mg - cytarabine 100mg - antineoplastic agents

ארצות הברית - אנגלית - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine 20 mg in 1 ml

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - cytarabine - solution for injection - 100mg/1ml

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cytarabine, quantity: 500 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - indications as at 24 october 2001: cytarabine is indicated primarily for: induction and maintenance of remission in acute myelocytic leukaemia of both adults and children. it has also been found to be useful in the treatment of other leukaemias such as acute lymphocytic leukaemia, chronic myelocytic leukaemia (blast phase). cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combined therapy. children with non-hodgkin's lymphoma have benefited from a combination drug program (lsa212) that includes cytarabine. remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity. cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

hospira, inc. - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative-free only) is indicated for the prophylaxis and treatment of meningeal leukemia. cytarabine is contraindicated in those patients who are hypersensitive to the drug.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

gland pharma limited - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine is contraindicated in those patients who are hypersensitive to the drug.